TScan Therapeutics Market Cap

TScan Therapeutics has a market cap or net worth of $474.18 million as of May 17, 2024. Its market cap has increased by 335.03% in one year.

Market Cap

474.18M

Enterprise Value

398.13M

1-Year Change

335.03%

Ranking

#3030

Market Cap Chart

Since the IPO on July 16, 2021, TScan Therapeutics's market cap has increased from $359.08M to $474.18M, an increase of 32.06%. That is a compound annual growth rate of 10.29%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	474.70M	0.89%
May 16, 2024	470.50M	-0.34%
May 15, 2024	472.10M	-0.65%
May 14, 2024	475.20M	12.23%
May 13, 2024	423.40M	14.40%
May 10, 2024	370.10M	-0.91%
May 9, 2024	373.50M	-2.61%
May 8, 2024	383.50M	-7.61%
May 7, 2024	415.10M	-1.59%
May 6, 2024	421.80M	2.90%
May 3, 2024	409.90M	-1.04%
May 2, 2024	414.20M	0.36%
May 1, 2024	412.70M	11.63%
Apr 30, 2024	369.70M	0.54%
Apr 29, 2024	367.70M	4.91%
Apr 26, 2024	350.50M	0.40%
Apr 25, 2024	349.10M	-1.22%
Apr 24, 2024	353.40M	1.67%
Apr 23, 2024	347.60M	1.97%
Apr 22, 2024	340.90M	4.38%
Apr 19, 2024	326.60M	-1.42%
Apr 18, 2024	331.30M	2.51%
Apr 17, 2024	323.20M	-5.33%
Apr 16, 2024	341.40M	-7.28%
Apr 15, 2024	368.20M	-0.78%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Enhabit	434.35M
Mereo BioPharma Group	428.08M
Korro Bio	423.39M
C4 Therapeutics	420.40M
Replimune Group	418.05M
Candel Therapeutics	410.87M
Annexon	410.14M
MultiPlan	405.56M

Market Cap Rankings